Remedy Robotics
Robotics
3 open rolesRoboticsSan Francisco, United States18 employees$35M raisedEst. 2020
Blackbird Ventures
Build Collective
DCVC
Divergent Capital
KdT Ventures
About Remedy Robotics
- Remedy Robotics is a medical technology company building the world's first remotely operable endovascular robotic platform, the Remedy N1 system.
- It aims to revolutionize cardiovascular care by enabling specialists to perform flawless, immediate endovascular interventions for conditions like stroke, heart attack, bleeding, and aneurysms, regardless of the patient's location.
Remedy Robotics is listed on Rocketlist with 3 active roles. The company is categorized as Robotics in MedTech. Remedy Robotics is at Series A stage, with a B2B business model, headquartered in San Francisco, United States. Remedy Robotics was founded in 2020 and has 18 employees. Remedy Robotics has raised $35M. Active roles are refreshed daily from public hiring sources.